Related Experiment Video
Updated: Aug 27, 2025
Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
Microenvironment immune response induced by tumor ferroptosis-the application of nanomedicine
Tian Yun1, Zhenzhu Liu2, Jianbo Wang1
1Department of Urology, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Abstract:
Ferroptosis is a non-apoptotic regulatory form of cell death that has sparked significant interest and research in cancer treatment and certain small chemical inducers have been used in the clinic. These inducers's weak water solubility, poor targeting, rapid metabolism; and other undesirable characteristics; however, for therapeutic approaches that combine immunotherapy and ferroptosis, challenges such as medication delivery, the complexity of the tumor microenvironment, and immunosuppression remain. The targeted, low toxicity, and efficient distribution benefits of nanotechnology have considerably enhanced the therapeutic efficacy of combining immunotherapy with ferroptosis. This paper describes the distinct mechanism of ferroptosis in tumor therapy and immunotherapy, as well as the application and benefits of nanotechnology in the combination of tumor immunotherapy and ferroptosis.
Systematic Review Registration:
http://clinicaltrials.gov/, NCT00941070.
Insights
Ferroptosis, a cell death pathway, shows promise in cancer therapy. Nanotechnology enhances combined ferroptosis and immunotherapy by improving drug delivery and overcoming tumor microenvironment challenges.
Area of Science:
- Oncology
- Immunology
- Biotechnology
Background:
- Ferroptosis is a regulated cell death pathway with therapeutic potential in cancer.
- Current ferroptosis inducers face challenges like poor solubility and targeting.
- Combining ferroptosis with immunotherapy is promising but hindered by delivery and tumor microenvironment issues.
Approach:
- This paper reviews the mechanism of ferroptosis in tumor therapy and immunotherapy.
- It explores the application and benefits of nanotechnology in combined ferroptosis and immunotherapy.
- Nanotechnology offers targeted delivery, low toxicity, and efficient distribution.
Key Points:
- Ferroptosis mechanisms in tumor therapy and immunotherapy are distinct.
- Nanotechnology significantly enhances the efficacy of combined ferroptosis and immunotherapy.
- Targeted delivery and overcoming immunosuppression are key benefits of nanotechnology.
Conclusions:
- Nanotechnology is crucial for overcoming challenges in combining ferroptosis and immunotherapy.
- Improved drug delivery and tumor microenvironment modulation are key advantages.
- This combination strategy holds significant potential for advanced cancer treatment.
Related Concept Videos
02:17The Tumor Microenvironment
01:27Tumor Immunotherapy